THERAHEART INC. has raised $11.6M in total funding. The most recent round was Series B.
THERAHEART INC. is headquartered in Irvine, CA.
Heart failure is a lifelong condition (affecting 1 in 4 people, with only 52% surviving past 5 years) that causes frequent hospitalization, shortness of breath, fatigue, swelling, and chest pain, and carries roughly $100B in healthcare costs.
Theraheart is a medical device manufacturer developing minimally invasive technologies aimed at improving outcomes for heart failure patients.
Founded by Wei Gan, Ph.D.; the cardiac device maker has raised over $11M, with Qiming Venture Partners among its investors.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.